Centro de Investigaciones Biológicas-ko ikertzaileekin lankidetzan egindako argitalpenak (7)

2016

  1. Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities

    Cancer Cell International, Vol. 16, Núm. 1

2015

  1. Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

    Annals of Hematology, Vol. 94, Núm. 3, pp. 379-392

2014

  1. Apoptotic efficacy of etomoxir in human acute myeloid leukemia cells. Cooperation with arsenic trioxide and glycolytic inhibitors, and regulation by oxidative stress and protein kinase activities

    PLoS ONE, Vol. 9, Núm. 12

  2. Regulation of death induction and chemosensitizing action of 3-bromopyruvate in myeloid leukemia cells: Energy depletion, oxidative stress, and protein kinase activity modulations

    Journal of Pharmacology and Experimental Therapeutics, Vol. 348, Núm. 2, pp. 324-335

2012

  1. 2-Deoxy-d-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: Involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways

    Biochemical Pharmacology, Vol. 84, Núm. 12, pp. 1604-1616

  2. Raf/MEK/ERK signaling inhibition enhances the ability of dequalinium to induce apoptosis in the human leukemic cell line K562

    Experimental Biology and Medicine, Vol. 237, Núm. 8, pp. 933-942

2011

  1. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation

    Biochemical Pharmacology, Vol. 82, Núm. 11, pp. 1619-1629